32168 Federal Register / Vol. 87, No. 103 / Friday, May 27, 2022 / Notices 

payment, specifying: The amounts 

withheld; and the dates that the 

withholding began and ended. 

Paragraph (g) of FAR clause 52.232– 

27 requires contractors to issue a written 

notice of any withholding to a 

subcontractor (with copy to the 

contracting officer), specifying— 

• The amount to be withheld; 

• The specific causes for the 

withholding under the terms of the 

subcontract; and 

• The remedial actions to be taken by 

the subcontractor in order to receive 

payment of the amounts withheld. 

Paragraph (l) of FAR clause 52.232–27 

requires contractors to remit 

overpayments to the payment office 

cited in the contract along with a 

description that includes the following: 

• Circumstances of the overpayment 

(e.g., duplicate payment, erroneous 

payment, liquidation errors, date(s) of 

overpayment); 

• Affected contract number and 

delivery order number if applicable; 

• Affected line item or subline item, 

if applicable; and 

• Contractor point of contact. 

Contractors are required to provide a 

copy of the remittance and supporting 

documentation to the contracting 

officer. 

The information is used to understand 

when the contractor withholds amounts 

from subcontractors and suppliers after 

the Government has already paid the 

contractor the amounts withheld. 

FAR 52.232–34, Payment by 

Electronic Funds Transfer—Other than 

System for Award Management. This 

clause requires contractors to provide 

the following information to enable the 

Government to make payments under 

the contract by EFT: 

Æ The contract number (or other 

procurement identification number). 

Æ The contractor’s name and 

remittance address. 

Æ The signature, title, and telephone 

number of the contractor official 

authorized to provide this information. 

Æ The name, address, and 9-digit 

Routing Transit Number of the 

contractor’s financial agent. 

Æ The contractor’s account number 

and the type of account. 

Æ If applicable, the Fedwire Transfer 

System telegraphic abbreviation of the 

contractor’s financial agent. 

Æ If applicable, the contractor must 

provide the name, address, telegraphic 

abbreviation, and 9-digit Routing 

Transit Number of the correspondent 

financial institution receiving the wire 

transfer payment if the contractor’s 

financial agent is not directly on-line to 

the Fedwire Transfer System. 

The burden to provide the 

information required by the FAR clause 

at 52.232–33, Payment by Electronic 

Funds Transfer—System for Award 

Management, is covered by OMB 

Control Number 9000–0189, Certain 

Federal Acquisition Regulation Part 4 

Requirements. OMB Control Number 

9000–0189 accounts for new 

registrations and renewals in the System 

for Award Management, which includes 

providing the EFT information. 

The information is used to enable the 

Government to make contract payments 

by EFT. 

C. Annual Burden 

Respondents: 275,319. 

Total Annual Responses: 1,817,432. 

Total Burden Hours: 471,947. 

D. Public Comment 

A 60-day notice was published in the 

Federal Register at 87 FR 1599, on 

March 21, 2022. Two comments were 

received; however, they did not change 

the estimate of the burden. 

Comments: One of the comments is 

not related to the information collection. 

The other comment is a vendor’s 

presentation of their products and 

services regarding payment solutions. 

Response: The commenters did not 

express an opinion on whether the 

estimated number of burden hours is 

accurate; or ways to minimize the 

burden of the collection of information. 

The information collection revision 

does not reflect any changes to the FAR 

requirements. Adjustments are made to 

the public and Government burden 

estimates based on the most recent data 

available. 

Obtaining Copies: Requesters may 

obtain a copy of the information 

collection documents from the GSA 

Regulatory Secretariat Division, by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. 9000–0073, Certain Federal 

Acquisition Regulation Part 32 

Requirements. 

Janet Fry, 

Director, Federal Acquisition Policy Division, 

Office of Governmentwide Acquisition Policy, 

Office of Acquisition Policy, Office of 

Governmentwide Policy. 

[FR Doc. 2022–11389 Filed 5–26–22; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Office of Refugee 

Resettlement Cash and Medical 

Assistance Program Quarterly Report 

on Expenditures and Obligations 

(ORR–2) (OMB #0970–0407) 

AGENCY: Office of Refugee Resettlement, 

Administration for Children and 

Families, HHS. 

ACTION: Request for public comment. 

SUMMARY: The Office of Refugee 

Resettlement (ORR), Administration for 

Children and Families (ACF) is 

requesting a 3-year extension of the 

form ORR–2, Cash and Medical 

Assistance Program Quarterly Report on 

Expenditures and Obligations (OMB 

#0970–0407, expiration 9/30/2022). 

There are no changes requested to the 

form. 

DATES: Comments due within 60 days of 

publication. In compliance with the 

requirements of the Paperwork 

Reduction Act of 1995, ACF is soliciting 

public comment on the specific aspects 

of the information collection described 

above. 

ADDRESSES: You can obtain copies of the 

proposed collection of information and 

submit comments by emailing 

infocollection@acf.hhs.gov. Identify all 

requests by the title of the information 

collection. 

SUPPLEMENTARY INFORMATION: 

Description: ORR reimburses, to the 

extent of available appropriations, 

certain non-federal costs for the 

provision of cash and medical 

assistance (CMA) to refugees, along with 

allowable expenses for the 

administration of the refugee 

resettlement program at the state level. 

States and Replacement Designees 

currently submit the ORR–2 Quarterly 

Report on Expenditures and 

Obligations, which provides aggregate 

expenditure and obligation data. The 

ORR–2 collects expenditures and 

obligations data separately for each of 

the four following CMA program 

components: Refugee cash assistance, 

refugee medical assistance, CMA 

administration, and services for 

unaccompanied minors. This 

breakdown of financial status data 

allows ORR to track program 

expenditures in greater detail to 

anticipate any funding issues and to 

meet the requirements of ORR 

regulations at CFR 400.211 to collect 

these data for use in estimating future 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 103 / Friday, May 27, 2022 / Notices 32169 

costs of the refugee resettlement 

program. ORR must implement the 

methodology at CFR 400.211 each year 

after receipt of its annual appropriation 

to ensure that appropriated funds will 

be adequate for reimbursement to states 

of the costs for assistance provided to 

entering refugees. The estimating 

methodology prescribed in the 

regulations requires the use of actual 

past costs by program component. If the 

methodology indicates that 

appropriated funds are inadequate, ORR 

must take steps to reduce federal 

expenses, such as by limiting the 

number of months of eligibility for 

Refugee Cash Assistance and Refugee 

Medical Assistance. The ORR–2 is a 

single-page financial report that allows 

ORR to collect the necessary data to 

ensure that funds are adequate for the 

projected need and thereby meet the 

requirements of both the Refugee Act 

and ORR regulations. 

Respondents: State governments and 

Replacement Designees. 

ANNUAL BURDEN ESTIMATES

Instrument 

Total 

number of 

respondents 

Total 

number of 

responses per 

respondent 

Average 

burden hours 

per response 

Annual 

burden 

hours 

ORR–2, Cash and Medical Assistance Program Quarterly Report on Expenditures and Obligations .......................................................................... 66 4 1.5 396 

Estimated Total Annual Burden 

Hours: 396. 

Comments: The Department 

specifically requests comments on (a) 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Consideration will be given 

to comments and suggestions submitted 

within 60 days of this publication. 

Authority: 8 U.S.C. 1522 Sec. 412 and 

8 U.S.C. 524 (Title IV), Sec. 414. 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–11409 Filed 5–26–22; 8:45 am] 

BILLING CODE 4184–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2013–N–0557] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Postmarket 

Surveillance of Medical Devices 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA, Agency, or we) is 

announcing an opportunity for public 

comment on the proposed collection of 

certain information by the Agency. 

Under the Paperwork Reduction Act of 

1995 (PRA), Federal Agencies are 

required to publish notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension an 

existing collection of information, and 

to allow 60 days for public comment in 

response to the notice. This notice 

solicits comments on information 

collection requirements for postmarket 

surveillance of medical devices. 

DATES: Submit either electronic or 

written comments on the collection of 

information by July 26, 2022. 

ADDRESSES: You may submit comments 

as follows. Please note that late, 

untimely filed comments will not be 

considered. Electronic comments must 

be submitted on or before July 26, 2022. 

The https://www.regulations.gov 

electronic filing system will accept 

comments until 11:59 p.m. Eastern Time 

at the end of July 26, 2022. Comments 

received by mail/hand delivery/courier 

(for written/paper submissions) will be 

considered timely if they are 

postmarked or the delivery service 

acceptance receipt is on or before that 

date. 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2013–N–0557 for ‘‘Agency Information 

Collection Activities; Proposed 

Collection; Comment Request; 

Postmarket Surveillance of Medical 

Devices.’’ Received comments, those 

filed in a timely manner (see 

ADDRESSES), will be placed in the docket 

and, except for those submitted as 

‘‘Confidential Submissions,’’ publicly 

viewable at https://www.regulations.gov 

or at the Dockets Management Staff 

between 9 a.m. and 4 p.m., Monday 

through Friday, 240–402–7500. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 


jspears on DSK121TN23PROD with NOTICES1